Suchergebnisse - "Lubell, Yoel"

PubPharm (204)

71

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia : A cluster randomised trial

enthalten in: PLoS medicine | 2019

von von Seidlein, L. | Peto, T. | Landier, J. | +70

72

How context can impact clinical trials : a multi-country qualitative case study comparison of diagnostic biomarker test interventions

enthalten in: Trials | 2019

von Haenssgen, M. | Charoenboon, N. | Do, N. | +4

73

How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions

enthalten in: Trials | 2019

von Haenssgen, M. | Charoenboon, N. | Do, N. | +4

74

How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions

enthalten in: Trials | 2019

von Haenssgen, M. | Charoenboon, N. | Do, N. | +4

75

Accounting for aetiology : can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?

enthalten in: Wellcome open research | 2019

von Chandna, A. | White, L. | Pongvongsa, T. | +4

76

Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar : an open-label, randomised, controlled trial

enthalten in: The Lancet. Global health | 2019

von Althaus, T. | Greer, R. | Swe, M. | +23

CommentIn: Lancet Glob Health. 2019 Jan;7(1):e14-e15. - PMID 30554750

77

C-reactive protein point of care testing in the management of acute respiratory infections in the Vietnamese primary healthcare setting – a cost benefit analysis

enthalten in: Antimicrobial resistance and infection control | 2018

von Lubell, Y. | Do, N. | Nguyen, K. | +8

78

C-reactive protein point of care testing in the management of acute respiratory infections in the Vietnamese primary healthcare setting – a cost benefit analysis

enthalten in: Antimicrobial resistance and infection control | 2018

von Lubell, Y. | Do, N. | Nguyen, K. | +8

79

Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

enthalten in: Antimicrobial resistance and infection control | 2018

von Shrestha, P. | Cooper, B. | Coast, J. | +7

80

Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

enthalten in: Antimicrobial resistance and infection control | 2018

von Shrestha, P. | Cooper, B. | Coast, J. | +7